• Value Pillars
  • Supplier Diversity
  • Supplier Standards
  • What We Do
  • How We Hire
  • Job Spotlight
  • Employee Benefits
  • Students
  • Innovation
  • Career Stories
  • Corporate Governance
  • Quarterly Results
  • SEC Filings
  • News Releases
  • Pharmaceutical Pipeline
  • 2018 Janssen Transparency Report
  • 2018 Health for Humanity Report
  • Stock Information
  • Webcasts & Presentations
  • Investor Fact Sheet
  • Global Community Impact
  • Global Public Health
  • Global Environmental Health
  • Citizenship & Sustainability Reporting
  • Follow Us
  • Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.
    Image courtesy of MTV Staying Alive Foundation
    When Syed Raza Ahmed took a role playing a 20-something living with TB, he knew he had a responsibility to educate others and help reduce stigma. As his MTV show debuts, he sat down with us to reveal what he's learned about the world's deadliest infectious disease.
    It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
    Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.
    Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
    Brilliant, outside-the-box ideas to help people live without illness as they live longer. That's what Johnson & Johnson and the National Academy of Medicine are looking for through a unique collaboration—and they’re putting up millions of dollars in prize money to find them.
    Alex Tait / Jelly London
    From a promising alternative for the flu shot to hope for a "universal" vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.
  • Fact
    16 million Americans have a smoking-related disease. But these strategies can help you kick the habit.
  • Recent Johnson & Johnson Initiatives in the Spotlight

    Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
    This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
    You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
    Continue